Juan C. Molero, et.al., c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action., The Journal of clinical investigation, 2004, 114

http://rdf.ncbi.nlm.nih.gov/pubmed/15520865

Juan C. Molero, et.al., c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action., The Journal of clinical investigation, 2004, 114

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• hyperactivity_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0001399I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• polyphagia_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0001433I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• decreased white adipose tissue amount_Cbl<tm1Ddlb>/Cbl<+>
  http://metadb.riken.jp/0001783I129S1SvC57BL6Cbltm1DdlbCblCblCbltm1Ddlb
• abnormal glucose homeostasis_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0002078I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• abnormal muscle physiology_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0002106I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• abnormal lipid homeostasis_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0002118I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
他15件を見る
• decreased circulating free fatty acid level_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0002702I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• decreased circulating insulin level_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0002727I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• increased insulin sensitivity_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0002891I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• abnormal gas homeostasis_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0003948I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• increased lean body mass_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0003960I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• increased oxygen consumption_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0005289I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• improved glucose tolerance_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0005292I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• increased body temperature_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0005533I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• decreased circulating leptin level_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0005668I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• abnormal fat cell morphology_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0009115I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• decreased liver triglyceride level_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0009356I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• decreased total body fat amount_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0010025I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• decreased respiratory quotient_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0010379I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• increased mitochondria size_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0011630I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb
• increased muscle cell glucose uptake_Cbl<tm1Ddlb>/Cbl<tm1Ddlb>
  http://metadb.riken.jp/0030021I129S1SvC57BL6Cbltm1DdlbCbltm1DdlbCbltm1Ddlb